1. Home
  2. RCEL vs MGYR Comparison

RCEL vs MGYR Comparison

Compare RCEL & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • MGYR
  • Stock Information
  • Founded
  • RCEL N/A
  • MGYR 1922
  • Country
  • RCEL United States
  • MGYR United States
  • Employees
  • RCEL N/A
  • MGYR N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • MGYR Savings Institutions
  • Sector
  • RCEL Health Care
  • MGYR Finance
  • Exchange
  • RCEL Nasdaq
  • MGYR Nasdaq
  • Market Cap
  • RCEL 107.8M
  • MGYR 107.3M
  • IPO Year
  • RCEL N/A
  • MGYR 2006
  • Fundamental
  • Price
  • RCEL $3.42
  • MGYR $16.58
  • Analyst Decision
  • RCEL Buy
  • MGYR
  • Analyst Count
  • RCEL 5
  • MGYR 0
  • Target Price
  • RCEL $11.80
  • MGYR N/A
  • AVG Volume (30 Days)
  • RCEL 260.2K
  • MGYR 1.7K
  • Earning Date
  • RCEL 11-06-2025
  • MGYR 10-30-2025
  • Dividend Yield
  • RCEL N/A
  • MGYR 2.14%
  • EPS Growth
  • RCEL N/A
  • MGYR 27.11
  • EPS
  • RCEL N/A
  • MGYR 1.56
  • Revenue
  • RCEL $74,884,000.00
  • MGYR $35,207,000.00
  • Revenue This Year
  • RCEL $20.40
  • MGYR N/A
  • Revenue Next Year
  • RCEL $32.94
  • MGYR N/A
  • P/E Ratio
  • RCEL N/A
  • MGYR $10.78
  • Revenue Growth
  • RCEL 38.32
  • MGYR 11.78
  • 52 Week Low
  • RCEL $3.37
  • MGYR $12.10
  • 52 Week High
  • RCEL $14.16
  • MGYR $19.04
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 28.06
  • MGYR 37.63
  • Support Level
  • RCEL $3.88
  • MGYR $16.76
  • Resistance Level
  • RCEL $3.91
  • MGYR $17.14
  • Average True Range (ATR)
  • RCEL 0.23
  • MGYR 0.14
  • MACD
  • RCEL -0.05
  • MGYR -0.01
  • Stochastic Oscillator
  • RCEL 0.00
  • MGYR 0.00

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.

Share on Social Networks: